儿童难治性肺炎支原体肺炎生物标志物研究进展
Research Progress on Biomarkers of Refractory Mycoplasma pneumoniae Pneumonia in Children
DOI: 10.12677/ACM.2024.143685, PDF,  被引量   
作者: 邓如玉, 罗征秀*：重庆医科大学附属儿童医院呼吸科，重庆；国家儿童健康与疾病临床医学研究中心，重庆；儿童发育疾病研究教育部重点实验室，重庆；儿科学重庆市重点实验室，重庆
关键词: 难治性肺炎支原体肺炎；生物标志物；Refractory Mycoplasma pneumoniae Pneumonia； Biomarkers
摘要: 肺炎支原体肺炎是儿童社区获得性肺炎重要组成部分，近年难治性肺炎支原体肺炎(refractory My-coplasma pneumoniae pneumonia, RMPP)发病率升高，肺炎支原体感染导致过度免疫炎症反应是RMPP发病的重要原因之一，因此检测免疫相关标志物有可能是早期预测RMPP的重要方法。本文就近年来儿童RMPP中新型免疫相关生物标志物及其预测作用进行综述。
Abstract: Mycoplasma pneumoniae is an important pathogen of community-acquired pneumonia in children. The incidence of refractory Mycoplasma pneumoniae pneumonia (RMPP) increased in recent years. It is accepted that the excessive immune inflammatory response caused by Mycoplasma pneumoni-ae infection is one of the important causes of RMPP. To measure the immune-related biomarkers could be an important method for early prediction of RMPP. We aim to review the novel im-mune-related biomarkers and their predictive roles in children with RMPP in this article.
文章引用：邓如玉, 罗征秀. 儿童难治性肺炎支原体肺炎生物标志物研究进展[J]. 临床医学进展, 2024, 14(3): 200-205. https://doi.org/10.12677/ACM.2024.143685

参考文献

[1] Song, M., Zhang, Y., Li, S., et al. (2017) A Sensitive and Rapid Immunoassay for Mycoplasma pneumoniae in Children with Pneumonia Based on Single-Walled Carbon Nanotubes. Scientific Reports, 7, Article No. 16442. [Google Scholar] [CrossRef] [PubMed]
[2] Zhang, H., Yang, J., Zhao, W., et al. (2023) Clinical Features and Risk Factors of Plastic Bronchitis Caused by Refractory Mycoplasma pneumoniae Pneumonia in Children: A Practi-cal Nomogram Prediction Model. European Journal of Pediatrics, 182, 1239-1249. [Google Scholar] [CrossRef] [PubMed]
[3] Liu, J.H., Liu, J.R., Tang, X.L., et al. (2023) Predictive Factors for Sequelae of Bronchitis Obliterans in Refractory Mycoplasma pneumoniae Pneumonia. Chinese Journal of Pediatrics, 61, 317-321.
[4] Wang, X., Zhong, L.J., Chen, Z.M., et al. (2018) Necrotizing Pneumonia Caused by Refractory My-coplasma Pneumonia Pneumonia in Children. World Journal of Pediatrics, 14, 344-349. [Google Scholar] [CrossRef] [PubMed]
[5] Song, S. and Xu, Y. (2023) A Retrospective Study of the Clinical Characteristics of 9 Children with Pulmonary Embolism Associated with Mycoplasma pneumoniae Pneumonia. BMC Pediatrics, 23, Article No. 370. [Google Scholar] [CrossRef] [PubMed]
[6] Tamura, A., Matsubara, K., Tanaka, T., et al. (2008) Methylprednisolone Pulse Therapy for Refractory Mycoplasma pneumoniae Pneumonia in Children. Journal of Infection, 57, 223-228. [Google Scholar] [CrossRef] [PubMed]
[7] 儿童肺炎支原体肺炎诊疗指南(2023年版) [J]. 全科医学临床与教育, 2023, 21(3): 196-202.
[8] Tong, L., Huang, S., Zheng, C., et al. (2022) Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management. Journal of Clinical Medicine, 11, Article No. 2824. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, S., Jiang, Z., Li, X., et al. (2023) Diagnostic Value of Se-rum LDH in Children with Refractory Mycoplasma pneumoniae Pneumoniae: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics, 11, Article ID: 1094118. [Google Scholar] [CrossRef] [PubMed]
[10] Lee, E. and Choi, I. (2022) Clinical Usefulness of Serum Lactate Dehydrogenase Levels in Mycoplasma pneumoniae Pneumonia in Children. Indian Journal of Pediatrics, 89, 1003-1009. [Google Scholar] [CrossRef] [PubMed]
[11] Zhao, J., Ji, X., Wang, Y., et al. (2020) Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children. Infection and Drug Resistance, 13, 835-843. [Google Scholar] [CrossRef] 
[12] Li, G., Fan, L., Wang, Y., et al. (2019) High Co-Expression of TNF-α and CARDS Toxin Is a Good Predictor for Refractory Mycoplasma pneumoniae Pneumonia. Molecular Medicine, 25, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
[13] Fan, F., Lv, J., Yang, Q., et al. (2023) Clinical Characteristics and Serum Inflammatory Markers of Community-Acquired Mycoplasma Pneumonia in Children. The Clinical Respiratory Journal, 17, 607-617. [Google Scholar] [CrossRef] [PubMed]
[14] Shen, F., Dong, C., Zhang, T., et al. (2022) Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children. Frontiers in Pediatrics, 10, Article ID: 813614. [Google Scholar] [CrossRef] [PubMed]
[15] Paudel, Y.N., Angelopoulou, E., Piperi, C., et al. (2019) Enlighten-ing the Role of High Mobility Group Box 1 (HMGB1) in Inflammation: Updates on Receptor Signalling. European Journal of Pharmacology, 858, Article ID: 172487. [Google Scholar] [CrossRef] [PubMed]
[16] Ding, Y., Chu, C., Li, Y., et al. (2018) High Expression of HMGB1 in Children with Refractory Mycoplasma pneumoniae Pneumonia. BMC Infectious Diseases, 18, Article No. 439. [Google Scholar] [CrossRef] [PubMed]
[17] Yang, Q., Li, M., Hou, Y., et al. (2023) High-Mobility Group Box 1 Emerges as a Therapeutic Target for Asthma. Immunity, Inflammation and Disease, 11, e1124. [Google Scholar] [CrossRef] [PubMed]
[18] Ren, W., Zhao, L., Sun, Y., et al. (2023) HMGB1 and Toll-Like Receptors: Potential Therapeutic Targets in Autoimmune Diseases. Molecular Medicine, 29, Article No. 117. [Google Scholar] [CrossRef] [PubMed]
[19] Ledford, J.G., Lo, B., Kislan, M.M., et al. (2010) Surfactant Protein-A Inhibits Mycoplasma-Induced Dendritic Cell Maturation through Regulation of HMGB-1 Cytokine Activity. The Journal of Immunology, 185, 3884-3894. [Google Scholar] [CrossRef] [PubMed]
[20] 徐迎春, 李北方, 张志刚. 肺泡灌洗液高迁移率族蛋白B1水平在难治性肺炎支原体肺炎患儿预后中的意义[J]. 实用临床医学, 2022, 23(1): 44-48.
[21] Buonacera, A., Stancanelli, B., Colaci, M., et al. (2022) Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships be-tween the Immune System and Diseases. International Journal of Molecular Sciences, 23, Article No. 3636. [Google Scholar] [CrossRef] [PubMed]
[22] Choi, Y.J., Jeon, J.H. and Oh, J.W. (2019) Critical Combination of Ini-tial Markers for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children: A Case Control Study. Respir-atory Research, 20, Article No. 193. [Google Scholar] [CrossRef] [PubMed]
[23] Guo, L., Liu, F., Lu, M.P., et al. (2015) Increased T Cell Activa-tion in BALF from Children with Mycoplasma pneumoniae Pneumonia. Pediatric Pulmonology, 50, 814-819. [Google Scholar] [CrossRef] [PubMed]
[24] Tamiya, S., Yoshikawa, E., Ogura, M., et al. (2021) Neutrophil-Mediated Lung Injury both via TLR2-Dependent Production of IL-1α and IL-12 P40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice. Microbiology Spectrum, 9, e0158821. [Google Scholar] [CrossRef] [PubMed]
[25] Tsai, C.Y., Hsieh, S.C., Liu, C.W., et al. (2021) Cross-Talk among Polymorphonuclear Neutrophils, Immune, and Non-Immune Cells via Released Cytokines, Granule Proteins, Microvesi-cles, and Neutrophil Extracellular Trap Formation: A Novel Concept of Biology and Pathobiology for Neutrophils. In-ternational Journal of Molecular Sciences, 22, Article No. 3119. [Google Scholar] [CrossRef] [PubMed]
[26] 张芙荣, 周卫芳, 李玉琴, 等. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值在重症肺炎支原体肺炎中的诊断价值[J]. 中华实用儿科临床杂志, 2022, 37(4): 260-264.
[27] Ling, Y., Ning, J. and Xu, Y. (2021) Explore the Pre-dictive Value of Peripheral Blood Cell Parameters in Refractory Mycoplasma pneumoniae Pneumonia in Children over 6 Years Old. Frontiers in Pediatrics, 9, Article ID: 659677. [Google Scholar] [CrossRef] [PubMed]
[28] Li, D., Gu, H., Chen, L., et al. (2023) Neutrophil-to-Lymphocyte Ratio as a Predictor of Poor Outcomes of Mycoplasma pneumoniae Pneumonia. Frontiers in Immunology, 14, Article ID: 1302702. [Google Scholar] [CrossRef] [PubMed]
[29] Mahroum, N., Alghory, A., Kiyak, Z., et al. (2022) Ferri-tin—From Iron, through Inflammation and Autoimmunity, to COVID-19. Journal of Autoimmunity, 126, Article ID: 102778. [Google Scholar] [CrossRef] [PubMed]
[30] De Palma, R.G., Hayes, V.W. and O’Leary, T.J. (2021) Optimal Serum Ferritin Level Range: Iron Status Measure and Inflammatory Biomarker. Metallomics, 13, mfab030. [Google Scholar] [CrossRef] [PubMed]
[31] Wen, J., Su, Y., Sun, H., et al. (2021) The Combination of Initial Markers to Predict Refractory Mycoplasma pneumoniae Pneumonia in Chinese Children: A Case Control Study. Respir-atory Research, 22, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[32] Hughes, C.E. and Nibbs, R.J.B. (2018) A Guide to Chemokines and Their Receptors. The FEBS Journal, 285, 2944-2971. [Google Scholar] [CrossRef] [PubMed]
[33] Inamura, N., Miyashita, N., Hasegawa, S., et al. (2014) Management of Refractory Mycoplasma pneumoniae Pneumonia: Utility of Measuring Serum Lactate Dehydrogenase Level. Journal of Infection and Chemotherapy, 20, 270-273. [Google Scholar] [CrossRef] [PubMed]
[34] Fan, Y., Ding, Y., Li, Y., et al. (2022) Investigation of the Rela-tionship between Community-Acquired Respiratory Distress Syndrome Toxin and the High-Mobility Group Box Protein 1-Toll-Like Receptors-Myeloid Differentiation Factor 88 Signaling Pathway in Mycoplasma pneumoniae Pneumonia. Italian Journal of Pediatrics, 48, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
[35] Medina, J.L., Coalson, J.J., Brooks, E.G., et al. (2014) Myco-plasma pneumoniae CARDS Toxin Exacerbates Ovalbumin-Induced Asthma-Like Inflammation in BALB/C Mice. PLOS ONE, 9, e102613. [Google Scholar] [CrossRef] [PubMed]
[36] Medina, J.L., Coalson, J.J., Brooks, E.G., et al. (2012) Myco-plasma pneumoniae CARDS Toxin Induces Pulmonary Eosinophilic and Lymphocytic Inflammation. American Journal of Respiratory Cell and Molecular Biology, 46, 815-822. [Google Scholar] [CrossRef] 
[37] Chu, Y.T., Chiang, W., Wang, T.N., et al. (2010) Changes in Serum Eotaxin and Eosinophil Cationic Protein Levels, and Eo-sinophil Count during Treatment of Childhood Asthma. Journal of Microbiology, Immunology and Infection, 40, 162-167.
[38] Tregoning, J.S., Pribul, P.K., Pennycook, A.M., et al. (2010) The Chemokine MIP1alpha/CCL3 Deter-mines Pathology in Primary RSV Infection by Regulating the Balance of T Cell Populations in the Murine Lung. PLOS ONE, 5, e0009381. [Google Scholar] [CrossRef] [PubMed]
[39] Salvatore, C.M., Techasaensiri, C., Taglia-bue, C., et al. (2009) Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cyto-kines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia. Antimicrobial Agents and Chemo-therapy, 53, 1546-1551. [Google Scholar] [CrossRef] 
[40] Lee, Y.C., Chang, C.H., Lee, W.J., et al. (2021) Altered Chemokine Profile in Refractory Mycoplasma pneumoniae Pneumonia Infected Children. Journal of Mi-crobiology, Immunology and Infection, 54, 673-679. [Google Scholar] [CrossRef] [PubMed]
[41] Gibellini, L., De Biasi, S., Paolini, A., et al. (2020) Altered Bioen-ergetics and Mitochondrial Dysfunction of Monocytes in Patients with COVID-19 Pneumonia. EMBO Molecular Medi-cine, 12, e13001. [Google Scholar] [CrossRef] [PubMed]
[42] Zhu, J., Liu, X., Zhan, X., et al. (2023) Predictive Value of Chemokines (CCL 2) in Bronchoalveolar Lavage Fluid for Refractory Mycoplasma Pneumonia in Children. Italian Journal of Pediatrics, 49, Article No. 125. [Google Scholar] [CrossRef] [PubMed]
[43] Zhang, W.H., Zhou, M.P., Zou, Y.Y., et al. (2023) The Predic-tive Values of Soluble B7-DC in Children with Refractory Mycoplasma pneumoniae Pneumonia. Translational Pediat-rics, 12, 396-404. [Google Scholar] [CrossRef] [PubMed]
[44] 付彬彬, 钟兰兰, 叶婷婷, 等. Autotaxin对儿童难治性肺炎支原体肺炎的预测价值及其与炎性细胞因子的相关性[J]. 中国当代儿科杂志, 2022, 24(7): 765-770.

为你推荐